Tag: equity
-
Biotech Start-Up Gains $90M for Neurodegenerative Diseases
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds.
-
Psychedelic Therapy Company Raises $80M in New Funds
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round.
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.
-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds.
-
ALS Drug Maker Gains $135M in New Funds
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round.
-
Infographic – 2021 Black Start-Up Funding Rises
Venture funding for Black-owned start-ups in the U.S. rose to record levels in the first half of 2021, but the percentage of total funding remains low.
-
Immune Cell Cancer Biotech Gains $172M in New Funds
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round.
-
Precision Gene-Editing Biotech Gains $200M in New Funds
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections.
-
Infographic – U.S. Leads Record Q2 Venture Funding
Venture capital financing broke global records in the second quarter of 2021, with investments in the U.S. accounting for nearly half of all dollars invested.